The Phillies, Direct Relief International and Teva Respiratory Team to Promote Asthma Awareness

- Asthma Awareness Event Open to the Public - PHILADELPHIA, June 22 /PRNewswire/ -- The Phillie Phanatic, 2008 World Series trophy and Phillies Ballgirls will be on hand at the Haddington Health Center, a part of Spectrum Health Services, to promote asthma awareness. Stop by for photos with T...

Statement by Teva Pharmaceuticals on Eshoo-Barton Bill

NORTH WALES, Pa., March 17 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the leading generic pharmaceutical company, today released the following statement by Debra Barrett, Senior Vice President of Government Affairs on the introduction of a biogenerics bill by Representatives Anna Eshoo a...

Barr Shareholders Approve Pending Teva Acquisition

MONTVALE, N.J., Nov. 21 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL ) today announced that its shareholders overwhelmingly approved the proposals submitted to them relating to the acquisition of Barr by Teva Pharmaceuticals Industries Ltd. (Nasdaq: TEVA ). "Today'...

Fitness and Figure Professionals Kirsten Nicewarner and Michelle Adams to Represent GNC at Vail's Teva Mountain Games

Plus, see the GNC Ultimate Mountain Challenge! PITTSBURGH, June 3 /PRNewswire/ -- GNC will host fitness and figure competitors Kirsten Nicewarner and Michelle Adams at the 2008 Teva Mountain Games Thursday through Sunday in Vail Valley, Colo. Both International Federation of Bodyb...

GPhA Announces 2008-2009 Executive Committee; Teva North America's Bill Marth Elected as Chairman of the Board

BOCA RATON, Fla., Feb. 12 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) Board of Directors today named the members of its newly elected Executive Committee and announced the election of William Marth, President and CEO of Teva North America, to serve as its Chairman for 2008- 2...

OrthoLite Joins the Teva U.S. Mountain Running Team

Signed as official insole for Mountain Running Team AMHERST, Mass., Feb. 11 /PRNewswire/ -- OrthoLite recently signed on as the official insole of the 2008 Teva U.S. Mountain Running Team. OrthoLite is the world's leading supplier of open cell foam insoles in the performance and foot...

Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Teva's Launch of Generic Pantoprazole

- Settlement Possible; Significant Obstacles Remain - COLLEGEVILLE, Pa., Jan. 21 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), announced today that it has agreed with Teva Pharmaceuticals USA, Inc. to extend the standstill period previously announ...

Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector

Barrett, David Schlotterbeck Named Vice Chairmen DUBLIN, Ohio, Jan. 10 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced that George S. Barrett, chief executive officer (CEO...

AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva

WILMINGTON, Del., Nov. 25 /PRNewswire-FirstCall/ -- AstraZeneca today announced it has entered into a settlement agreement in its Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA. The agreement sett...

US Court Allows Teva to Deliver Disputed Drug: Novartis

A US court has authorised Israeli generic medicines group Teva to resume deliveries of a blood pressure drug despite a patent lawsuit by Novartis, the Swiss pharmaceutical group said on Tuesday . A US federal court judge in New Jersey rejected on Monday a request from Novartis to stop Teva Pharmace...

Teva in Medical Technology

Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS)

SWARTZ CREEK, Mich., Oct. 10 /PRNewswire/ -- Diplomat Specialty Pharmacy announced today that Teva Neuroscience has selected Diplomat Specialty Pharmacy to be one of only three sites to participate in a large scale, national Therapy Optimization Study for Multiple Sclerosis (TOP MS). The goa...

Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering

LEXINGTON, Mass., Sept. 26 /PRNewswire/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) today announced that it has signed a development, license and commercialization agreement with Teva Pharmaceutical Industries Ltd. for the exclusive, worldwide rights to pagoclone. Indevus previously anno...

UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients

...ug designation in the U.S. and in Europe. Gamida Cell's current shareholders include: Elbit Imaging, Biomedical Investment, Israel Healthcare Venture, teva Pharmaceuticals, Amgen, Denali Ventures and Auriga Ventures. CONTACT: Courtney McCrimmon Wendy Zellner UPMC Media Relations P...

CEL-SCI Corporation Releases Letter to Shareholders

...of 2008: We signed a Multikine(R) licensing agreement with teva Pharmaceuticals , one of the top 20 pharmaceutical companies in the world. teva will participate in and pay for part of the Multikine Phase III trial. ...

ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis

...xecutive Officer of Isis. "ATL/TV1102 and ATL's strategic relationship with teva to move the drug forward further validates our business strategy. ATL has s... a potential treatment for prostate cancer. ATL/TV1102 has been licensed to teva Pharmaceutical Industries Ltd. About Isis Pharmaceuticals, Inc. Isis is...

Isis Pharmaceuticals Conference Call Notice

...esults of the TV-1102 clinical trial and the ATL / teva / Isis relationship. -- ATL and teva announced clinical data on TV-1102 demonstrating p...se.com.au/_home.asp to view the release titled: teva Pharmaceuticals & Antisense Therapeutics Announce ...

PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimer's Disease

...d spun out 65 companies. Yissum's business partners span the globe and include companies such as Novartis, Microsoft, Johnson & Johnson, Merck, Intel, teva and many more. Statement on Cautionary Factors Except for the historical information presented herein, matters discussed may constitute forward-lo...

BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality

... pharmaceutical companies seeking their next blockbuster drugs. The Company was founded in 2003 by leaders in the Israeli life science arena including teva Pharmaceuticals Ltd, Giza, Pitango, Hadasit and the Jerusalem Development Authority. For more information, please visit www.biolinerx.com. Contact ...

First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone Was More Cost-Effective Than Interferon Beta Therapies for Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

...ntis. In North America, COPAXONE(R) is marketed by teva Neuroscience, Inc., which is a subsidiary of teva Pharmaceutical Industries Ltd (NASDAQ:TEVA). COPAX...trademark of Teva Pharmaceutical Industries Ltd. teva Pharmaceutical Industries Ltd., headquartered in I...

Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)

...ASDAQ:TEVA). In Europe, COPAXONE(R) is marketed by teva Pharmaceutical Industries Ltd. and sanofi-aventis....trademark of Teva Pharmaceutical Industries Ltd. teva Pharmaceutical Industries Ltd., headquartered in I...competing generic equivalents, the extent to which teva may obtain U.S. market exclusivity for certain of ...

Teva in Biological News

Environmental peace treaty between Israel and Palestinians unveiled at Ben-Gurion University

... Mohammad Said Al-Hmaida from Bir Zeit University. Tal is a long-time environmental activist who founded the a public interest advocacy group Adam teva V'din the Israel Union for Environmental Defense, while Al-Hmaidi is a past director general of the Ministry of the Environment of the Palestinian Au...

Systems biologist finds novel solutions to fundamental biological problems

...stigator (2001-2004). She has received several prestigious awards including the Helen and Martin Kimmel Award for Innovative Investigation (2007), the teva Prize for Research in Systems Biology (2005), the Morris L. Levinson Biology Prize from the Weizmann Institute of Science (2004) and the Michael Bruno...

Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone

...nion Israel Institute of Technology, the Weizmann Institute of Science and teva Pharmaceutical Industries have recently identified genes responsible for th...cant step toward realizing this medical vision. In the collaborative study, teva supplied DNA samples from drug-treated patients, and the genetic tests were...

Teva in Biological Technology

Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.

REHOVOT, Israel and JERSEY CITY, New Jersey, January 8 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), the leading developer of microRNA-based molecular diagnostics, announced today it has signed an exclusive distribution agreement with Teva Pharmaceutical Industries Ltd. Under...

Codexis, Teva in Licensing Agreement Final

REDWOOD CITY, Calif., Jan. 7 /PRNewswire/ -- Codexis, Inc. today announced a licensing agreement with Teva Pharmaceutical Industries Ltd., to produce an important publicly-undisclosed generic product, using a proprietary Codexis biocatalyst. Teva, the largest generic drug manufacturer in the ...

CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine

VIENNA, Va., Aug. 19 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (Amex: CVM ) announced today that it has entered into an exclusive licensing agreement with Teva Pharmaceutical Industries Ltd. (Teva), a leading global pharmaceutical company, under which CEL-SCI has granted Teva an exclusive...

Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals

TOKYO and WOODCLIFF LAKE, N.J., March 28 /PRNewswire/ -- Eisai Co., Ltd. and its U.S. subsidiary Eisai Inc. (collectively "Eisai") today announced that the United States District Court for the District of New Jersey has ruled in Eisai's favor with respect to Eisai's motion for a preliminary in...

Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent

COLLEGEVILLE, Pa., Dec. 24 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), today announced it will pursue a patent infringement claim for lost profits and other damages against Teva Pharmaceuticals USA, Inc. resulting from Teva's launch of a pantoprazole tab...

Prix Galien USA Announces 2009 Final Candidates

...is Oncology, GLEEVEC(R) Novartis Pharmaceuticals, EXELON(R)( )PATCH Pfizer, Zyvox(R) Schering-Plough, TEMODAR(R) and ZETIA(R) teva Neurosciences, AZILECT(R) Wyeth, TORISEL(R) Best Biotechnology Product: Amgen, Nplate(R) GlaxoSmithKline, PROMACTA...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... to $67 million, as a result of the launch by teva Pharmaceuticals Industries Ltd ("Teva") of a... for the treatment of ADHD - On April 2, 2009 teva announced that it had commenced commercial s...ing the launch of an authorized generic version by teva in April 2009. Excluding ADDERALL XR, product sale...

Sanofi-aventis Announces Second Quarter 2009 Results

...ainst euro 178 million in the first half of 2008, primarily as a result of the royalty equal to 25% of sales of Copaxone((R)) in North America paid by teva to sanofi-aventis with effect from the second quarter of 2008. Operating income - current advanced by 20.7% to euro 5,944 million. At constan...

IKARIA(R) to In-License BioLineRx's BL-1040

...ch companies to further the development of promising compounds. The Company was founded in 2003 by leaders in the Israeli life science arena including teva Pharmaceuticals Ltd., venture capital firms Giza Venture Capital and Pitango Venture Capital, and Hadasit, the technology transfer company of Hadassah...

Clinical Pharmacology Study With AZILECT(R) (Rasagiline Tablets) Demonstrated It Does Not Increase Tyramine Sensitivity

...Dose KANSAS CITY, Mo., June 9 /PRNewswire/ -- teva Neuroscience, Inc. today presented results from a ...bjectives," said Jon Congleton, general manager of teva Neuroscience. "This study provides continuing evid...ults of this study have been submitted to FDA, and teva Neuroscience intends to work with FDA to appropria...

Teva in Biological Dictionary

Uropod

... response when the treadmill ... Product Condition: The Uropod Dry Bag - 37L is in Like New condition. ... bombproof waterproof construction, the teva Uropod Dry Bag stays high and dry on the water. ... The uropod , a protrusion at the rear of amoeboid motile cells such as leukocytes, ... Rem...